| abstract |
The present invention relates to a novel biarylamide derivative represented by the following formula (1) having affinity for an aldosterone receptor, or a pharmacologically acceptable salt thereof. [Wherein, A is any group represented by the following formula (a) or the like; L is —CONH— or the like; R 1 is an optionally substituted aminosulfonyl group or the like; R 2 is a hydrogen atom or the like; R 3 is a hydrogen atom or the like; R 4 is a hydrogen atom, a halogen atom, a hydroxy group, an optionally substituted amino group, or an optionally substituted C; A 1-6 alkoxy group, an optionally substituted 4- to 7-membered cyclic amino group and the like; R 5a , R 5b and R 5c are each independently a hydrogen atom; R 6 is A halogen atom, a cyano group, and the like, and R 7 and R 8 are each independently a hydrogen atom; m is an integer such as 0; ] |